| Term 
 
        | Brand name for rituximab? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | CD-20 target on lymphocytes kills the cancer but also releases cytokines |  | 
        |  | 
        
        | Term 
 
        | Where much rituximab infusions be given? |  | Definition 
 
        | Infusions must be given in hospital or clinic since they can be fatal!   (there are A LOT of side effects associated with rituximab)   |  | 
        |  | 
        
        | Term 
 
        | Severe infusion reactions occur with rituximab normally when, and what should be given prior to rituximab infusions? |  | Definition 
 
        | Severe reactions typically occur during the first infusion with time to onset of 30 - 120 minutes. Administer diphenhydramine and APAP prior to infusion |  | 
        |  | 
        
        | Term 
 
        | How ford iodine 131 affect cells |  | Definition 
 
        | Iodine 131 induces cellular damage by the formation of free radicals in the target and neighboring cells |  | 
        |  | 
        
        | Term 
 
        | Cytokine release syndrome is associated with tositumomoab thus pretreat with what to decrease its occurance? |  | Definition 
 
        | Premedication with acetaminophen and diphenhydramine. |  | 
        |  | 
        
        | Term 
 
        | What kind of protective medication needs to be given prior to tositumomab? |  | Definition 
 
        | Thyroid - protective iodine regimen |  | 
        |  | 
        
        | Term 
 
        | What severe side effect is associated with Alemtuzumab? |  | Definition 
 
        | severe-prolonged myelosuppression |  | 
        |  | 
        
        | Term 
 
        | What is given as prophylaxis for Alemutuzumab? |  | Definition 
 
        | TMP/SMZ and famciclovir for a minimum of 2 months or until CD4 counts are > 200 cells/liter   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | How do platinum - based compounds work? |  | Definition 
 
        | X-links DNA, leading to apoptosis |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Brand name for Carboplatin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Brand name for Oxaliplatin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Severe side effects associated with Cisplatin? |  | Definition 
 
        | Nephrotoxicity - vigorous hydration and sometimes mannitol used to avoid renal failure; electrolyte wasting requiring magnesium and potassium supplementation. Amifostine (Ethyol) may also be used prophylactically.   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | How do Vinca Alkaloids work? |  | Definition 
 
        | Inhibit microtube function (destabilizers) |  | 
        |  | 
        
        | Term 
 
        | Brand name for Vincristine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Brand name for Vinblastine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Brand name for Vinorelbine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | with vincristine, nerve damage is associated with? |  | Definition 
 
        | cumulative (dose-dependent) |  | 
        |  | 
        
        | Term 
 
        | With vinca alkaloids, vesication occurs when what happens and how to treat? |  | Definition 
 
        | Vesication occurs when extravasated, treat with injections of hyaluronidase and moderate heat |  | 
        |  | 
        
        | Term 
 
        | How are vinca alkaloids administered? |  | Definition 
 
        | IV only; Do not administer intrathecally - fatal   |  | 
        |  | 
        
        | Term 
 
        | what side effect is common with vincristine? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | How do purine analog antimetabolites work? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which of the purine analogs undergo extensive first pass metabolism in the liver by xanthine oxidase. And how does allopurinol hinder this? |  | Definition 
 
        | 6-mercaptopurine (6-MP). Allopurinol inhibits its first metabolism thus resulting in a raise in 6-MP bioavailability by 400 to 500%.     |  | 
        |  | 
        
        | Term 
 
        | The dose of 6-MP should be increased or decreased when given concomitantly with allopurinol? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | When a drug has myelosuppression as a side effect what is the prophylaxis given? |  | Definition 
 
        | trimethoprim-sulfamethoxazole prophylaxis against Pneumocytsis jiroveci |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | How do primidine analog antimetabolites work? |  | Definition 
 
        | inhibit pyrimidine synthesis |  | 
        |  | 
        
        | Term 
 
        | Brand name for fluorouracil |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | topical formulation of 5-FU for wrinkles |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | topical formulation of 5-FU for psoraisis |  | 
        |  | 
        
        | Term 
 
        | When 5-FU is given for chemo, what should also be given to increase efficacy? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What kind of deficiency can increase risk of 5-FU toxicity? |  | Definition 
 
        | dihydropyrimidine dehydrogenase (DPD) deficiency |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prodrug of 5-FU, it's taken PO with meals   |  | 
        |  | 
        
        | Term 
 
        | Brand name for Capecitabine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What drug does capecitabine seriously affect? |  | Definition 
 
        | Capecitabine increases INR up to 91% due to 2C9 inhibition; required decreased warfarin dosage/INR monitoring |  | 
        |  | 
        
        | Term 
 
        | Brand name for Gemcitabine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How is Gemcitabine administered? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | How to Hypomethylating agents work? |  | Definition 
 
        | Restore normal function to genes (DNA) that are critical for differentiation and proliferation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Taxanes inhibit microtubule function and angiogenesis (dyfunctional microtubule bundling) |  | 
        |  | 
        
        | Term 
 
        | Brand name for Paciltaxel |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Brand name for Paciltaxel albumin-bound |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What's so special about Abraxane? |  | Definition 
 
        | less HSN rxns, does not require pre-medication |  | 
        |  | 
        
        | Term 
 
        | The pre-treatment for paciltaxel |  | Definition 
 
        | Pre-treat with:   dexamethasone diphenhydramine H2-blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | serious side effect with Docetaxel? |  | Definition 
 
        | cardio-pulmonary: Fluid retention |  | 
        |  | 
        
        | Term 
 
        | the pre-treatment for docetaxel |  | Definition 
 
        | Pretreatment with:   dexamethasone 8mg BID x 3 days starting the day prior to docetaxel  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | Name a topoisomerase II inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Name topoisomerase I inhibitors |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Brand name for Irinotecan |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | What significant drug interaction do all tyrosine kinase inhibitors have? |  | Definition 
 
        | all the TKIs have significant drug interactions with the CYP 450 system especially 3A4   |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | PO, 1 hr before, 2 hr after meal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PO, with water and full meal, NO grapefruit juice |  | 
        |  | 
        
        | Term 
 
        | Tyrosine Kinase inhibitos respod better to what type of lung cancer? |  | Definition 
 
        | K-ras wild type lung cancer |  | 
        |  | 
        
        | Term 
 
        | which populations have higher incidence of K-ras wild type genetics? |  | Definition 
 
        | K-ras wild type in Asians and light smokers or non-smokers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intercalcating agent blocking topoisomerase II |  | 
        |  | 
        
        | Term 
 
        | the most common side effect associated with bleomycin |  | Definition 
 
        | Pulmonary reactions (10%) |  | 
        |  | 
        
        | Term 
 
        | Brand name for hydroxyurea |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | used as a debulking agent in leukemia and in sickle cell disease |  | 
        |  | 
        
        | Term 
 
        | How does hydroxyurea work? |  | Definition 
 
        | inhibits the conversion of ribonucelotides to deoxyribonucleotides |  | 
        |  | 
        
        | Term 
 
        | Brand name for aresenic trioxide |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how does arsenic toxide work? |  | Definition 
 
        | induces terminal differentiation of cells or apoptosis |  | 
        |  | 
        
        | Term 
 
        | serious side effect of arsenic? |  | Definition 
 
        | QT-prolongation: monitor ECG, avoid concurrent QT prolonging agents, keep Mg+ and K+ within normal range |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a quesiton. |  | 
        |  | 
        
        | Term 
 
        | What is Sipuleucel-T (Provenge) |  | Definition 
 | 
        |  |